Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students
Condition(s):Wellness, Psychological; Well-Being, PsychologicalLast Updated:January 26, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Wellness, Psychological; Well-Being, PsychologicalLast Updated:January 26, 2024Active, not recruiting
Condition(s):Appetite and General Nutritional DisordersLast Updated:May 6, 2021Completed
Condition(s):Iron Deficiency (Without Anemia)Last Updated:July 10, 2020Completed
Condition(s):Periodontitis; InflammationLast Updated:August 3, 2021Completed
Condition(s):Cachexia; CancerLast Updated:June 22, 2017Completed
Condition(s):Cachexia; CancerLast Updated:January 30, 2015Completed
Condition(s):Type 2 DiabetesLast Updated:November 25, 2022Active, not recruiting
Condition(s):Subjective Cognitive Complaints; MindfulnessLast Updated:March 13, 2018Completed
Condition(s):Major InjuryLast Updated:March 20, 2018Completed
Condition(s):Micronutrient DeficienciesLast Updated:March 11, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.